Discover how the innovative pharmaceutical industry works with partners to advance the SDGs
Read moreOn 2 February 2023, IFPMA delivered a statement for the agenda item related to the prevention and control of non-communicable diseases and mental health at the WHO EB152.
Read moreIFPMA delivered a constituency statement for the agenda item related to strengthening the global architecture for health emergency preparedness, response, and resilience at the 152nd session of the Executive Board at the World Health Organization in Geneva.
Read more